Iontophoretic transdermal delivery and control of adverse side-effects
US6018679A · kind A · utility
60Cited by
28References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 29, 1997 |
| Grant date | Jan 25, 2000 |
| Priority date | — |
| Expiry date | Jan 29, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/325
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A method is disclosed for iontophoretically removing any compound that is capable of causing skin irritation or other harmful effects. More specifically, a bipolar iontophoretic transdermal delivery method is disclosed that includes a reversal phase for controlling the iontophoretic transdermal delivery of pharmaceutical compounds while reducing or eliminating skin irritation and terminating the pharmacological or toxicological effects in skin of drugs/cosmetics/active ingredients which form a drug depot in the skin after passive or iontophoretic application.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.